{
    "nct_id": "NCT03147768",
    "official_title": "Phase I Feasibility Trial To Study The Safety Of Sealing Resected Pancreatic Surfaces After Partial Distal Pancreatectomy Using Laser Tissue Welding",
    "inclusion_criteria": "Eligible participants will be 18 years and older of both genders.\n\n1. T1a (≤ 4 cm, as measured by the maximal dimension by CT or MRI). Final determination of disease stage is made during the operation by the investigator. All resectable cystic, benign, primary or secondary malignant tumors.\n2. Serum creatinine: ≤ 2.5 mg/dL\n3. Glomerular filtration rate greater than ≥ 50 ml/min/m2\n4. Platelet count ≥ 50,000/mm3\n5. Prothrombin time < 18 seconds\n6. PTT not >1.5 times control (except for therapeutically; anticoagulated nonrelated medical conditions [e.g., atrial fibrillation]);\n7. Serum albumin levels > 3g/dL (Normal range 3.5 to 5 g/dL)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Age younger than 18 years' old\n2. Severe uncorrected hypertension (> 180 systolic and >110 diastolic)\n3. Uncorrectable coagulopathies (on Plavix, Aspirin or Lovanox)\n4. Pregnancy\n5. Females who are breast feeding who do not switch the infant to formula prior to surgery\n6. Active urinary tract infection\n7. T1b (>4 cm) lesion and above\n8. Systemic or local infection.\n9. Subject has known allergy or intolerance to iodine or human serum albumin.\n10. Recent febrile illness that precludes or delays participation preoperatively.\n11. Treatment with another investigational drug or other intervention during the study and follow-up period.\n12. Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.",
    "miscellaneous_criteria": ""
}